ArticleBMC microbiology2026
Specific monitoring of viable plant growth-promoting Bacillus velezensis PH-023 in the rhizosphere of tomato.
Article in BMC microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPlant growth-promoting bacteria (PGPB) must be able to successfully colonize the plant rhizosphere and remain viable after their release into the field to exert beneficial effects on crop production. Therefore, understanding the behavioral dynamics of PGPB in the rhizosphere is a key challenge to evaluate their persistence and fate under field conditions. This study aimed to develop and validate a strain-specific viability quantitative PCR (v-qPCR) assay for monitoring the viable population dynamics of the PGPB B. velezensis PH-023 in the rhizosphere.
resultsA v-qPCR method was developed for the unambiguous detection and quantification of B. velezensis PH-023 viable cells and spores in the rhizosphere of tomato. The TaqMan-based qPCR assay was designed within a PH-023-specific molecular marker. The nucleic acid-binding dye PMAxx was used in combination with qPCR to selectively amplify DNA of only viable cells. The v-qPCR showed good linearity over a 4-log range and good amplification efficiency. The performance of the v-qPCR method was assessed in the rhizosphere of tomato plants treated with a commercial biostimulant product based on B. velezensis PH-023 under greenhouse conditions and high and stable survival rates of PH-023 were confirmed by v-qPCR. Finally, confocal microscopy of stained roots of tomato plants inoculated with B. velezensis PH-023-based biostimulant product using a viability test showed preliminary evidence of association of the viable inoculated bacteria with the root surface, forming large cell aggregates in comparison with untreated plants.
conclusionsThis study offers a strategy to develop and validate a strain-specific viability qPCR method for monitoring the viable population of B. velezensis PH-023 and provides evidence for the colonization ability of this strain formulated as a commercial microbial biostimulant in the rhizosphere. The method will allow further studies of ecological fate, including colonization and survival under field conditions, as well as improvements in formulations and delivery strategies for consistent agricultural benefits. It is expected that the development of the v-qPCR presented here provides a reference for similar studies with other beneficial bacterial strains in different environments. As far as we know, the application of strain-specific v-qPCR approaches for the quantification of the viable population of Bacillus sp. strains in soil or rhizosphere samples have not been reported yet.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.